azelastine and maprotiline interaction

azelastine and maprotiline both increase sedation. Potential for interaction, monitor

azelastine and lurasidone interaction

lurasidone, azelastine. Either increases toxicity of the other by Other  

 Significant interaction possible, monitor closely 

 Potential for increased CNS depressant effects when used concurrently; monitor for increased adverse effects and toxicity

azelastine and loxapine interaction

azelastine and loxapine both increase sedation. Potential for interaction, monitor

azelastine and lormetazepam interaction

azelastine and lormetazepam both increase sedation. Potential for interaction, monitor

azelastine and lorazepam interaction

azelastine and lorazepam both increase sedation. Potential for interaction, monitor

azelastine and loprazolam interaction

azelastine and loprazolam both increase sedation. Potential for interaction, monitor

azelastine and lomitapide interaction

azelastine increases levels of lomitapide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Significant interaction possible, monitor closely. Lomitapide dose should not exceed 30 mg/day